Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D08RYE
|
|||
Former ID |
DNC000596
|
|||
Drug Name |
Efomycine M
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | E-selectin (SELE) | Target Info | Inhibitor | [1] |
P-selectin (SELP) | Target Info | Inhibitor | [1] | |
KEGG Pathway | Cell adhesion molecules (CAMs) | |||
Malaria | ||||
Staphylococcus aureus infection | ||||
TNF signaling pathway | ||||
African trypanosomiasis | ||||
NetPath Pathway | IL5 Signaling Pathway | |||
IL4 Signaling Pathway | ||||
TNFalpha Signaling Pathway | ||||
ID Signaling Pathway | ||||
Pathway Interaction Database | IL4-mediated signaling events | |||
amb2 Integrin signaling | ||||
Thromboxane A2 receptor signaling | ||||
Glucocorticoid receptor regulatory network | ||||
ATF-2 transcription factor network | ||||
Reactome | Platelet degranulation | |||
Cell surface interactions at the vascular wall | ||||
WikiPathways | Human Complement System | |||
Spinal Cord Injury | ||||
Cell surface interactions at the vascular wall | ||||
TNF alpha Signaling Pathway |
References | Top | |||
---|---|---|---|---|
REF 1 | Interfering with leukocyte rolling--a promising therapeutic approach in inflammatory skin disorders Trends Pharmacol Sci. 2003 Feb;24(2):49-52. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.